Advertisement
Advertisement
Money /

Markets & Investing

The global longevity market, fuelled by an ageing population and rising consumption demand, is currently valued at US$5.3 trillion, according to a UBS report. Photo: Shutterstock
China’s private sector

Insilico, US partner to build AI models predicting disease decades ahead

Tie-up combines Hong Kong-listed Insilico Medicine’s algorithms with Human Longevity’s genomic data to advance personalised health research.

Banking & finance

Xi-Trump meeting could lift Chinese stocks 12%: Morgan Stanley

Banking & finance

Hong Kong-listed firm uses AI to make nano-rockets to deliver life-saving drugs

videocam
China stock market

Emerging markets rebound on inflows as Xi-Trump talks eyed for momentum

Mainland China, Hong Kong stock markets may benefit from Xi-Trump meeting as renewed interest in AI shows investors keen to re-engage, analysts say.

videocam
People walk beneath a large screen showing stock exchange and economic data in Shanghai. Asia-Pacific markets have seen gains in recent months as geopolitical panic over the Iran war dissipates. Photo: EPA
People walk beneath a large screen showing stock exchange and economic data in Shanghai. Asia-Pacific markets have seen gains in recent months as geopolitical panic over the Iran war dissipates. Photo: EPA
Banking & finance

Hong Kong secures US$3.5 billion to fund Northern Metropolis and green projects

Global investors pile into city’s latest bond sale, with orders 7.6 times oversubscribed, backing its green finance ambitions.

Banking & finance

Biotech-led boom as 8 China firms flock to Hong Kong’s thriving stock market

AI-powered drug developer Metis TechBio leads group that includes developers of autonomous driving technology and industrial robots.

Advertisement
Advertisement
Advertisement
Banking & finance

Liquid courage: Hong Kong fund pitches whisky as alternative investment

Fund pitches spirit as hedge and sees downturn as a rare entry point, citing emotional buying and shifting consumption trends.

Whisky has been gaining traction among wealthy investors seeking alternatives to traditional safe havens, according to an investment firm. Photo: Shutterstock
Whisky has been gaining traction among wealthy investors seeking alternatives to traditional safe havens, according to an investment firm. Photo: Shutterstock
Banking & finance

Global funds fuel Hong Kong IPO rebound as investors rebalance China portfolios

AI, robotics and energy storage firms make up most of the record-high IPO pipeline in Hong Kong, says Chan.

Banking & finance

China healthcare stocks shine in Hong Kong amid Middle East turmoil

Hang Seng Healthcare Index outpaces broader market as Akeso, Innovent, Hansoh provide refuge for global investors.

Banking & finance

OKX Ventures, HashKey Capital back Vietnam crypto platform’s pilot scheme bid

Under pilot rules, at least 65 per cent of capital must come from institutional investors and foreign ownership is capped at 49 per cent.

This photo taken on February 12, 2026 shows a Vietnamese cryptocurrency investor looking at the latest bitcoin values on a smartphone in Hanoi. Photo: AFP
Banking & finance

Mainland China and Hong Kong IPOs drive Citic to the top of banking fee rankings

Citic leads Asia-Pacific in fees in the first quarter as IPOs in Hong Kong and mainland China offset weaker debt and M&A activity.

Citic Securities led Asia-Pacific with a 6.4 per cent share of the total investment banking fee pool in the first quarter: Photo. Reuters
Citic Securities led Asia-Pacific with a 6.4 per cent share of the total investment banking fee pool in the first quarter: Photo. Reuters
Banking & finance

Everest’s US$250 million buy signals rising global appetite for China biotech

Sovereign wealth funds from Singapore and Abu Dhabi join Chinese state capital as cross-border biotech licensing reaches record highs.

Banking & finance

Stricter Chinese scrutiny of offshore vehicles a blow for tech IPO candidates

Mainland’s stock market watchdog is discouraging establishment of ‘red-chip-structured’ companies in sensitive industries.

Banking & finance

Hong Kong’s anticipated stablecoin licence by end-March does not materialise

Analysts say the delay is most likely administrative and that the overall plan is still on track.

videocam
Hong Kong’s stablecoin initiative is part of efforts to become a global digital-asset hub. Photo: Getty Images
IPO

Hong Kong retains IPO crown but may lose to US mega listings over full year

Second place for IPO funds raised is Nasdaq, with US$5.65 billion from 18 listings, while the New York Stock Exchange ranks third.

An exterior view of the Hong Kong stock exchange in Central, February 6, 2026. Photo: Jonathan Wong
An exterior view of the Hong Kong stock exchange in Central, February 6, 2026. Photo: Jonathan Wong
Mainland China

Sketching a recovery: China puts next-gen art buyers in the frame amid slowdown

A US$83 trillion global wealth transfer in next two to three decades is beginning to reshape China’s art market: UBS.

Turkey

As tensions rise, Middle Eastern money and travellers pivot to Hong Kong

Wealthy Gulf visitors are extending their stays in Hong Kong as investors from the region look to hedge risk and tap Asian markets.

Advertisement
Advertisement
Advertisement
Banking & finance

Tong Ren Tang unit pulls Hong Kong IPO in first postponement this year

Hospital-network operator delays plan to raise up to US$115 million amid tepid demand.

videocam
A view of Exchange Square in Central, where Hong Kong’s bourse operator has its headquarters, on March 13, 2026. Photo: Jelly Tse
A view of Exchange Square in Central, where Hong Kong’s bourse operator has its headquarters, on March 13, 2026. Photo: Jelly Tse
China’s private sector

China’s obesity drug makers take on global giants as Novo Nordisk patent expires

Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss market.

China’s private sector

Rights to antibody drug from China’s Keymed change hands in US acquisition

Sichuan-based Keymed expects to receive up to US$320 million as a result of deal involving its autoimmune disease treatment licensed in 2024.

Banking & finance

Asian private equity values cash flow as fundraising falls to 12-year low

Advanced manufacturing and healthcare attract more attention at the expense of technology, media and telecommunications, Bain & Co says.

An employee works on a robot production line at Inovance Group in Jiangning District of Nanjing, in east China’s Jiangsu province, on March 17, 2026. Photo: Xinhua
Made in China 2025

Global drug giants double down on China amid push for self-reliant supply chains

Multinationals are building self-reliant supply chains in China to insulate local markets from potential trade disruptions, say analysts.

AstraZeneca’s booth at the China International Supply Chain Expo in Beijing, July 17, 2025. Photo: EPA
AstraZeneca’s booth at the China International Supply Chain Expo in Beijing, July 17, 2025. Photo: EPA
Banking & finance

Iran conflict drives fund managers to slash risk and hoard cash: BofA survey

Fund managers pile into cash at fastest pace since Covid-19 as geopolitical tensions, inflation replace AI as top concerns, bank finds.

Banking & finance

Chinese banks outpace rivals in Hong Kong wealth growth, Huatai HK CEO says

Booming listings and rising outbound investment demand are accelerating growth for Chinese players, SFC data shows.

China’s private sector

US reshoring drive casts shadow over China’s contract drug makers, analyst says

Strong order backlogs underpin earnings through 2027, but analysts warn longer-term demand is less certain as US firms reshore production.

Despite the headwinds, there is growing interest from multinational pharmaceutical companies in partnering with Chinese biotech firms. Photo: Getty Images
Help preserve 120 years of quality journalism.
SUPPORT NOW